The first four authors contributed equally to the work.
Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6–35 months: a randomized, double-blind, controlled phase I clinical trial
Article first published online: 8 NOV 2012
© 2012 John Wiley & Sons Ltd
Influenza and Other Respiratory Viruses
Volume 7, Issue 6, pages 1297–1307, November 2013
How to Cite
Li, Y.-P., Li, W., Liang, X.-F., Liu, Y., Huang, X.-C., Li, C.-G., Li, R.-C., Wang, J.-Z., Wang, H.-Q. and Yin, W.-D. (2013), Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6–35 months: a randomized, double-blind, controlled phase I clinical trial. Influenza and Other Respiratory Viruses, 7: 1297–1307. doi: 10.1111/irv.12028
- Issue published online: 5 NOV 2013
- Article first published online: 8 NOV 2012
- Accepted 26 August 2012. Published Online 7 November 2012.
- National High Technology Research
- Center for Disease Control and Prevention. Grant Number: 2010AA022908
- 1WHO. New influenza A (H1N1) virus: global epidemiological situation, June 2009. Wkly Epidemiol Rec2009; 84:249–257.
- 4Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust2009; 191:146–149., , , , .
- 6Centers for Disease Control and Prevention (CDC). Swine-origin influenza A (H1N1) virus infections in a school – New York City, April 2009. MMWR Morb Mortal Wkly Rep2009; 58:470–472.
- 10Centers for Disease Control and Prevention. Update: influenza activity, United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. MMWR Morb Mortal Wkly Rep2010; 59:423–430.
- 11Centers for Disease Control and Prevention (CDC). FluView: week 48 ending December 5, 2009. Available at http://www.cdc.gov/flu/weekly/ (Accessed 11 December 2009).
- 12National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep2009; 58:1–8.
- 20CBER/FDA. Regulatory Considerations Regarding the Use of Novel Influenza A (H1N1) Virus Vaccines: United States Food and Drug Administration, 2009.
- 23Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill2009; 14:pii: 19288., .
- 25Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev2008; 2:CD004879., , , , .